Home » Newsletters » BioWorld Science

BioWorld Science

May 24, 2017

View Archived Issues

Attune reports preclinical data on ATN-249 for treatment of hereditary angioedema

MATRIX trials reveal postoperative pain reduction with bupivacaine-collagen matrix INL-001

EMA grants orphan drug designation to avacopan for C3 glomerulopathy

Churchill Pharmaceuticals submits NDA for Yonsa

United Neuroscience reports phase I data on UB-311 for Alzheimer's disease

Dose-dependent effects of intranasal oxytocin evaluated in autism spectrum disorders

Global BioLife begins research on universal therapeutic drug platform

DNAnexus partners with AstraZeneca on genomics informatics

MK-7264 shows significant efficacy in patients with refractory chronic cough

FDA grants accelerated approval to Keytruda and priority review for further indication

Imfinzi available in U.S.

GlaxoSmithKline describes novel CPHPC prodrugs

Oryx reports data on ParvOryx combination therapy in GBM

Sutter Health, Dignity Health patent podophyllotoxin and camptothecin derivatives

Calithera Biosciences presents new arginase inhibitors

OSE and Selexis sign commercial license agreement

Northwestern University patents MNK1/2 inhibitors

Palladio Biosciences acquires rights to lixivaptan

WHO Situation Report documents rise in Ebola cases/New antibodies described

Phase III study of Livatag recommended to continue

Debiopharm acquires ImmunoGen's ADC IMGN-529

Spring Bank releases initial cohort data from phase IIa study of SB-9200 in HBV

FDA and EMA accept submissions for UX-003 for mucopolysaccharidosis VII

Neurocrine reports phase II data on Ingrezza in Tourette's syndrome

FDA grants breakthrough therapy designation to plazomicin

Pierre Fabre acquires immuno-oncology assets from Igenica Biotherapeutics

A new zebrafish model of amyotrophic lateral sclerosis shows relevance of the Nefl protein

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...